Volume 76, Issue 1, Pages (July 2019)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 5, Pages (November 2011)

Advertisements

Volume 71, Issue 2, Pages (February 2017)

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial) M. Yoshida, K. Muro, A. Tsuji,

Volume 50, Issue 1, Pages (July 2006)

Volume 60, Issue 2, Pages (August 2011)

Volume 44, Issue 6, Pages (December 2003)

European Urology Focus

Volume 58, Issue 4, Pages (October 2010)

Volume 70, Issue 1, Pages (July 2016)

Volume 70, Issue 6, Pages (December 2016)

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Volume 60, Issue 2, Pages (August 2011)

Volume 57, Issue 6, Pages (June 2010)

Volume 68, Issue 4, Pages (October 2015)

Volume 53, Issue 5, Pages (May 2008)

Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages 4-6 (January 2016)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Let the Games Begin (with EAU Approval)

Volume 68, Issue 1, Pages (July 2015)

Volume 71, Issue 2, Pages (February 2017)

Volume 73, Issue 4, Pages e116-e118 (April 2018)

Giuseppe Di Lorenzo, Riccardo Autorino, Cora N. Sternberg

Volume 63, Issue 1, Pages (January 2013)

Volume 68, Issue 4, Pages (October 2015)

Volume 65, Issue 5, Pages (May 2014)

Volume 66, Issue 2, Pages (August 2014)

Volume 74, Issue 1, Pages (July 2018)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 65, Issue 3, Pages (March 2014)

Volume 51, Issue 3, Pages (March 2007)

Volume 61, Issue 5, Pages (May 2012)

Volume 71, Issue 3, Pages (March 2017)

Volume 70, Issue 4, Pages (October 2016)

Volume 68, Issue 1, Pages (July 2015)

Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma Viktor Grünwald, Xun Lin, Daniel Kalanovic,

Volume 69, Issue 4, Pages (April 2016)

Volume 70, Issue 1, Pages (July 2016)

European Urology Oncology

Volume 65, Issue 6, Pages (June 2014)

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers Pasquale Rescigno, David Lorente, David Dolling, Roberta Ferraldeschi, Daniel.

Volume 70, Issue 2, Pages (August 2016)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Volume 66, Issue 2, Pages (August 2014)

Volume 68, Issue 4, Pages (October 2015)

Volume 52, Issue 1, Pages (July 2007)

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 62, Issue 3, Pages (September 2012)

Volume 71, Issue 2, Pages (February 2017)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 73, Issue 4, Pages e116-e118 (April 2018)

Volume 70, Issue 6, Pages (December 2016)

Bernard Escudier European Urology Supplements

Volume 74, Issue 3, Pages (September 2018)

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Volume 75, Issue 3, Pages (March 2019)

European Urology is “Your” Journal

Volume 68, Issue 5, Pages (November 2015)

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK–Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External.

Axel Heidenreich European Urology Supplements

Forest plots for all drugs (OS and PFS HRs combined): excellent versus reduced PS comparison and ECOG PS levels comparison (see online supplementary 1). ECOG.

Volume 67, Issue 4, Pages (April 2015)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Axel Heidenreich European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

European Urology Oncology

Volume 51, Issue 5, Pages (May 2007)

Kaplan–Meier analysis of PFS and OS in patients with advanced non-small cell lung cancer with adenocarcinoma histology with time since start of first-line.

Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma Guillermo de Velasco, Axel Bex, Laurence Albiges, Thomas Powles, Brian.

Presentation transcript:

Volume 76, Issue 1, Pages 73-81 (July 2019) Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract Cora N. Sternberg, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, Fernando Lopez-Rios, Giuseppe L. Banna, Ugo De Giorgi, Cristina Masini, Aristotelis Bamias, Xavier Garcia del Muro, Ignacio Duran, Thomas Powles, Marija Gamulin, Friedemann Zengerling, Lajos Geczi, Craig Gedye, Sabine de Ducla, Simon Fear, Axel S. Merseburger European Urology Volume 76, Issue 1, Pages 73-81 (July 2019) DOI: 10.1016/j.eururo.2019.03.015 Copyright © 2019 The Author(s) Terms and Conditions

Fig. 1 Efficacy in the intent-to-treat population: (A) overall survival (OS), (B) progression-free survival (PFS), and (C) duration of response. CI=confidence interval. European Urology 2019 76, 73-81DOI: (10.1016/j.eururo.2019.03.015) Copyright © 2019 The Author(s) Terms and Conditions

Fig. 2 Efficacy in the overall population and prespecified difficult-to-treat subgroups. CNS=central nervous system; ECOG PS=Eastern Cooperative Oncology Group performance status; OS=overall survival. European Urology 2019 76, 73-81DOI: (10.1016/j.eururo.2019.03.015) Copyright © 2019 The Author(s) Terms and Conditions